Literature DB >> 23124580

Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort.

Leslie J Cloud1, Adam Rosenblatt, Russel L Margolis, Christopher A Ross, Jagan A Pillai, Jody Corey-Bloom, Hannah M Tully, Thomas Bird, Peter K Panegyres, Charles A Nichter, Donald S Higgins, Sandra L Helmers, Stewart A Factor, Randi Jones, Claudia M Testa.   

Abstract

Little is known about the epilepsy that often occurs in the juvenile form of Huntington's disease (HD), but is absent from the adult-onset form. The primary aim of this study was to characterize the seizures in juvenile HD (JHD) subjects with regard to frequency, semiology, defining EEG characteristics, and response to antiepileptic agents. A multicenter, retrospective cohort was identified by database query and/or chart review. Data on age of HD onset, primary HD manifestations, number of CAG repeats, the presence or absence of seizures, seizure type(s), antiepileptic drugs used, subjects' response to antiepileptic drugs (AEDs), and EEG results were assembled, where available. Ninety subjects with genetically confirmed JHD were included. Seizures were present in 38% of subjects and were more likely to occur with younger ages of HD onset. Generalized tonic-clonic seizures were the most common seizure type, followed by tonic, myoclonic, and staring spells. Multiple seizure types commonly occurred within the same individual. Data on EEG findings and AED usage are presented. Seizure risk in JHD increases with younger age of HD onset. Our ability to draw firm conclusions about defining EEG characteristics and response to AEDs was limited by the retrospective nature of the study. Future prospective studies are required.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23124580     DOI: 10.1002/mds.25237

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  27 in total

1.  Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.

Authors:  Mark F Mehler; Jenna R Petronglo; Eduardo E Arteaga-Bracho; Maria E Gulinello; Michael L Winchester; Nandini Pichamoorthy; Stephen K Young; Christopher D DeJesus; Hifza Ishtiaq; Solen Gokhan; Aldrin E Molero
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

2.  ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 mice.

Authors:  Alipi V Naydenov; Eric A Horne; Christine S Cheah; Katie Swinney; Ku-Lung Hsu; Jessica K Cao; William Marrs; Jacqueline L Blankman; Sarah Tu; Allison E Cherry; Susan Fung; Andy Wen; Weiwei Li; Michael S Saporito; Dana E Selley; Benjamin F Cravatt; John C Oakley; Nephi Stella
Journal:  Neuron       Date:  2014-07-16       Impact factor: 17.173

3.  Inherited RORB pathogenic variants: Overlap of photosensitive genetic generalized and occipital lobe epilepsy.

Authors:  Lynette G Sadleir; Guillem de Valles-Ibáñez; Chontelle King; Matthew Coleman; Stuart Mossman; Sarah Paterson; John Nguyen; Samuel F Berkovic; Saul Mullen; Melanie Bahlo; Michael S Hildebrand; Heather C Mefford; Ingrid E Scheffer
Journal:  Epilepsia       Date:  2020-03-12       Impact factor: 5.864

Review 4.  Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.

Authors:  Sandra M Holley; Talia Kamdjou; Jack C Reidling; Brian Fury; Dane Coleal-Bergum; Gerhard Bauer; Leslie M Thompson; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2018-03-06       Impact factor: 5.243

Review 5.  Progress in developing transgenic monkey model for Huntington's disease.

Authors:  Brooke R Snyder; Anthony W S Chan
Journal:  J Neural Transm (Vienna)       Date:  2017-11-10       Impact factor: 3.575

6.  Neuropathological Comparison of Adult Onset and Juvenile Huntington's Disease with Cerebellar Atrophy: A Report of a Father and Son.

Authors:  Caitlin S Latimer; Margaret E Flanagan; Patrick J Cimino; Suman Jayadev; Marie Davis; Zachary S Hoffer; Thomas J Montine; Luis F Gonzalez-Cuyar; Thomas D Bird; C Dirk Keene
Journal:  J Huntingtons Dis       Date:  2017

Review 7.  Neuronal Network Oscillations in Neurodegenerative Diseases.

Authors:  Volker Nimmrich; Andreas Draguhn; Nikolai Axmacher
Journal:  Neuromolecular Med       Date:  2015-04-29       Impact factor: 3.843

8.  Morphological features in juvenile Huntington disease associated with cerebellar atrophy - magnetic resonance imaging morphometric analysis.

Authors:  Abderrahmane Hedjoudje; Gaël Nicolas; Alice Goldenberg; Catherine Vanhulle; Clémentine Dumant-Forrest; Guillaume Deverrière; Pauline Treguier; Isabelle Michelet; Lucie Guyant-Maréchal; Didier Devys; Emmanuel Gerardin; Jean-Nicolas Dacher; Pierre-Hugues Vivier
Journal:  Pediatr Radiol       Date:  2018-06-20

Review 9.  Juvenile Huntington's Disease: Diagnostic and Treatment Considerations for the Psychiatrist.

Authors:  Joanna Quigley
Journal:  Curr Psychiatry Rep       Date:  2017-02       Impact factor: 5.285

10.  Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.

Authors:  Eduardo E Arteaga-Bracho; Maria Gulinello; Michael L Winchester; Nandini Pichamoorthy; Jenna R Petronglo; Alicia D Zambrano; Julio Inocencio; Chirstopher D De Jesus; Joseph O Louie; Solen Gokhan; Mark F Mehler; Aldrin E Molero
Journal:  Neurobiol Dis       Date:  2016-09-10       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.